Combining cryoablation with GM-CSF exerted a potent antitumor effect, enhancing the number of DCs within the tumor microenvironment, bolstering the antitumor immune response, and extending the median survival time in mice bearing tumors. This evidence concerns the gene CSF2 and neoplasm.